Yarrow Bioscience (YARW) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 22 64 sessions, July 28, 2026 to October 26, 2026
- Largest daily move
- +17.9% close of September 17, 2026
- 1-month change
- -21.7% closing prices, September 25, 2026 to October 26, 2026
Company Description
Yarrow Bioscience (NASDAQ: YARW) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $168.3M.
YARW has declined 21.7% over the past month. The last closing price was $20.00.
For FY2025, Yarrow Bioscience reported revenue of $570K with net income of -$26.5M and diluted earnings per share of -$0.62.
This page collects what Stock Titan holds for YARW, including price data, latest news, SEC filings, financial highlights, upcoming events, and short interest trends.
Stock Performance
Yarrow Bioscience (YARW) closed at $20.00 on October 26, 2026. Over the past month, the price has lost 21.7%.
YARW Metrics & Rankings
Price returns through October 26, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Yarrow Bioscience has 5 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 4 with negative movement. Key topics include offering, earnings, acquisition, clinical trial. View all YARW news →
SEC Filings
Yarrow Bioscience has filed 10 recent SEC filings, including 4 Form SCHEDULE 13G, 2 Form 8-K, 2 Form 424B5, 1 Form EFFECT. The most recent filing was submitted on October 7, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all YARW SEC filings →
Financial Highlights
Yarrow Bioscience generated $570K in revenue in FY2025, operating income reached -$29.7M, and net income was -$26.5M. Diluted earnings per share stood at -$0.62. The company generated -$33.1M in operating cash flow. The current ratio was 12.53, measuring current assets divided by current liabilities.
Upcoming Events
Phase 2a data release
Phase 2a/2b topline data
Phase 2b start
Yarrow Bioscience has 3 upcoming scheduled events. The next event, "Phase 2a data release", is scheduled for July 1, 2027 (in 247 days). Investors can track these dates to stay informed about potential catalysts that may affect the YARW stock price.
Short Interest History
Short interest in Yarrow Bioscience (YARW) currently stands at 189.6 thousand shares, up 49.8% from the previous reporting period, representing 7.1% of the shares outstanding. Since July 2026, short interest has increased by 1406.8%.
Days to Cover History
Days to cover for Yarrow Bioscience (YARW) currently stands at 1.2 days, up 20% from the previous period. The ratio is the reported short interest divided by the average daily trading volume.
YARW Company Profile & Sector Positioning
Yarrow Bioscience (YARW) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.